Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Cash (2020 - 2025)

Historic Change in Cash for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$26.3 million.

  • Maravai Lifesciences Holdings' Change in Cash fell 62813.88% to -$26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$334.6 million, marking a year-over-year decrease of 2300656.08%. This contributed to the annual value of -$252.6 million for FY2024, which is 34172.9% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Change in Cash stood at -$26.3 million, which was down 62813.88% from -$15.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Change in Cash ranged from a high of $172.9 million in Q3 2021 and a low of -$255.8 million during Q4 2024
  • For the 5-year period, Maravai Lifesciences Holdings' Change in Cash averaged around $388947.4, with its median value being -$571000.0 (2023).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Change in Cash surged by 155069.38% in 2021 and then plummeted by 540846.44% in 2024.
  • Over the past 5 years, Maravai Lifesciences Holdings' Change in Cash (Quarter) stood at $3.4 million in 2021, then skyrocketed by 335.45% to $14.7 million in 2022, then plummeted by 131.6% to -$4.6 million in 2023, then plummeted by 5408.46% to -$255.8 million in 2024, then surged by 89.7% to -$26.3 million in 2025.
  • Its Change in Cash was -$26.3 million in Q3 2025, compared to -$15.1 million in Q2 2025 and -$37.3 million in Q1 2025.